Ultrasound in managing extrapulmonary tuberculosis: A randomised, controlled, parallel, superiority, open-label trial.
Robert NdegeOmary NgomeFiona VanobberghenFarida BaniYvan TembaHerieth WilsonJerry HellaWinfrid GingoMohamed SasamaloDorcas MnzavaNamvua KimeraHellen HizaJohn WigayiHerry MapesiIrene B KatoFrancis MhimbiraKlaus ReitherManuel BattegayDaniel H ParisMaja WeisserMartin RohacekPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
eFASH did not change the proportion of correctly managed patients, but increased the proportion of definite tuberculosis.
Keyphrases
- open label
- study protocol
- end stage renal disease
- clinical trial
- phase iii
- newly diagnosed
- ejection fraction
- phase ii
- chronic kidney disease
- magnetic resonance imaging
- hiv aids
- prognostic factors
- randomized controlled trial
- pulmonary tuberculosis
- emergency department
- human immunodeficiency virus
- hepatitis c virus
- patient reported outcomes
- drug induced
- placebo controlled